Trademark: 79352112
Word
DBL-4PEN
Status Date
Tuesday, April 16, 2024
Filing Date
Wednesday, August 3, 2022
Published for Opposition
Tuesday, April 16, 2024
9 Downloadable databases enabling computer storage and reading of data in the field of medicine; data processing equipment; recorded software for assisting users in managing glucose levels, bolus, carbohydrates and basal rates in the field of diabetes treatment; downloadable computer programs for assisting users in managing glucose levels, bolus, carbohydrates and basal rates in the field of diabetes treatment; downloadable electronic files featuring data information about diabetes downloadable onto a computer or a portable telephone; computer terminals; mobile data terminals and computer terminals; Internet and intranet servers; computer and network servers; database server centers comprising computer network servers; computer peripheral devices; intercommunication apparatus, namely telephones and dedicated mobile handsets incorporating intercommunication systems; interfaces for computers; electronic card readers being data processing equipment; downloadable electronic publications namely, e-books, magazines, newsletters, in the field of medicine; wearable activity trackers; magnetic identity cards; downloadable software applications for downloading and reading data from electronic devices in the field of medicine; downloadable mobile applications for downloading and reading electronic publications on portable electronic devices in the field of medicine; information display terminals, namely computer terminals; electronic devices for digital display, namely, electronic display interfaces; downloadable software for web applications for downloading electronic publications in the field of medicine; downloadable software applications for mobile telephones for downloading electronic publications in the field of medicine; downloadable applications for retrieval of information and data in the field of diabetes treatment; downloadable software applications for the transmission and management of data in the field of diabetes treatment
10 Test apparatus for medical purposes especially for the prevention and treatment of diabetes; diagnostic apparatus for medical use, namely, for testing blood sugar levels; blood testing apparatus; medical and surgical apparatus and instruments, namely, insulin pumps; pumps for medical use, namely, insulin pumps; detection apparatus for medical use, namely, for testing blood sugar levels; measuring devices for medical use, namely for testing blood sugar levels; medical diagnostic instruments, namely, for testing blood sugar levels; Insulin pens being insulin injectors sold empty; insulin pens sold empty; insulin syringes in the form of pens
42 Engineering services, namely, evaluations, assessments and research in the fields of science and technology provided by engineers; design and development of computers and software; research and development of new products for third parties; technical project studies, namely, conducting of feasibility studies in the field of medicine; development, design, installation, maintenance, and updating software; rental of software for the transmission and management of data in the field of diabetes treatment; computer programming; consultation with respect to computer technology; conversion of computer programs and data, other than physical conversion; conversion of data or documents from physical to electronic media; scientific research and development services especially within the scope of the prevention and treatment of diabetes; design and development of procedures and techniques for the prevention and treatment of diabetes; scientific analysis services with respect to medicine and health; scientific research in the nature of conducting clinical trials for others; chemical analysis; biological research; research in bacteriology; chemical research; development of software application solutions; providing temporary use of non-downloadable web-based applications for sharing and collaborating on web-based documents about the diabetes treatment; scientific analysis of data in the field of diabetes treatment and data concerning diabetes
DBL FOR PEN; DBL FOUR PEN
Nov 2, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Oct 13, 2022
Sn Assigned For Sect 66a Appl From Ib
Oct 14, 2022
New Application Office Supplied Data Entered
Oct 18, 2022
Application Filing Receipt Mailed
Oct 20, 2022
Assigned To Examiner
Nov 1, 2022
Non-Final Action Written
Jan 17, 2023
Refusal Processed By Mpu
Jan 17, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Feb 7, 2023
Refusal Processed By Ib
Apr 3, 2023
Change Of Name/Address Rec'd From Ib
Jul 13, 2023
Teas Response To Office Action Received
Jul 13, 2023
Correspondence Received In Law Office
Jul 13, 2023
Teas/Email Correspondence Entered
Aug 29, 2023
Final Refusal Written
Aug 29, 2023
Final Refusal E-Mailed
Aug 29, 2023
Notification Of Final Refusal Emailed
Mar 12, 2024
Examiners Amendment -Written
Mar 12, 2024
Examiners Amendment E-Mailed
Mar 12, 2024
Notification Of Examiners Amendment E-Mailed
Mar 12, 2024
Examiner's Amendment Entered
Mar 12, 2024
Approved For Pub - Principal Register
Mar 13, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 13, 2024
Notification Of Possible Opposition Sent To Ib
Mar 27, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 27, 2024
Notification Of Notice Of Publication E-Mailed
Apr 1, 2024
Notification Of Possible Opposition - Processed By Ib
Mar 27, 2024
Notification Of Possible Opposition Sent To Ib
Apr 16, 2024
Published For Opposition
Apr 16, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 15, 2024
Notification Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
